PATH | VRL
Menu

Neither Antibody to a Group B Streptococcal Conjugate Vaccine nor the Vaccine Itself is Teratogenic in Rabbits

This article, published in Human Vaccines, describes a group B Streptococcus (GBS) type-III capsular polysaccharide (CPS)-tetanus toxoid vaccine lot manufactured under current Good Manufacturing Practice Guidelines. The authors also provide an evaluation of the effect of this vaccine and of GBS type-III CPS-specific antibody on conception and early- and late-stage fetal development in rabbits.

Author: Paoletti LC, Guttormsen H-K, Christian MS, Hoberman AM, McInnes P

Published: 2008

» Visit web page (English)

(Located at www.tandfonline.com)

Citation: Paoletti LC, Guttormsen H-K, Christian MS, Hoberman AM, McInnes P. Neither Antibody to a Group B Streptococcal Conjugate Vaccine nor the Vaccine Itself is Teratogenic in Rabbits. Human Vaccines. 2008;4(6):435-443. 

Resource types: Peer-reviewed journal

Diseases/vaccines: Group B Streptococcus (GBS)

Topics: Vaccine safety and performance, Disease/vaccine specific information, Vaccine stabilization and formulation

Regions: North America and Europe